Equities

Neuroone Medical Technologies Corp

NMTC:NAQ

Neuroone Medical Technologies Corp

Actions
FinancialsInvestment Banking and Brokerage Services
  • Price (USD)0.89
  • Today's Change-0.01 / -1.11%
  • Shares traded21.23k
  • 1 Year change-32.58%
  • Beta0.7663
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects Neuroone Medical Technologies Corp share price to rise to 3.15 in the next year from the last price of 0.89.
High253.9%3.15
Med253.9%3.15
Low253.9%3.15

Earnings history & estimates in USD

Earnings forecasts are not available for Neuroone Medical Technologies Corp. On Aug 14, 2024, Neuroone Medical Technologies Corp reported 3rd quarter 2024 losses of -- per share.
Average growth rate+13.65%
Neuroone Medical Technologies Corp reported annual 2023 losses of -0.65 per share on Dec 14, 2023.
Average growth rate+14.54%
More ▼

Revenue history & estimates in USD

NeuroOne Medical Technologies Corporation had 3rd quarter 2024 revenues of 826.00k. This was 47.39% below the prior year's 3rd quarter results.
Average growth rate+12.49%
NeuroOne Medical Technologies Corporation had revenues for the full year 2023 of 1.95m. This was 1,041.52% above the prior year's results.
Average growth rate+518.79%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.